Repligen Corporation (RGEN)
USD 122.9
(6.69%)
USD 122.9
(6.69%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 853.2 Million USD | 38.97% |
| 2022 | 613.95 Million USD | 0.93% |
| 2021 | 608.28 Million USD | 62.76% |
| 2020 | 373.73 Million USD | 9.81% |
| 2019 | 340.34 Million USD | 119.55% |
| 2018 | 155.01 Million USD | 2.04% |
| 2017 | 151.91 Million USD | 26.44% |
| 2016 | 120.14 Million USD | 411.51% |
| 2015 | 23.48 Million USD | 51.92% |
| 2014 | 15.46 Million USD | 4.76% |
| 2013 | 14.75 Million USD | 14.54% |
| 2012 | 12.88 Million USD | 147.45% |
| 2011 | 5.2 Million USD | -1.74% |
| 2010 | 5.29 Million USD | 14.43% |
| 2009 | 4.63 Million USD | -2.15% |
| 2008 | 4.73 Million USD | 33.79% |
| 2007 | 3.53 Million USD | 11.73% |
| 2006 | 3.16 Million USD | -4.56% |
| 2005 | 3.31 Million USD | 35.36% |
| 2004 | 2.45 Million USD | 9.25% |
| 2003 | 2.24 Million USD | -15.88% |
| 2002 | 2.66 Million USD | 112.18% |
| 2001 | 1.25 Million USD | 4.99% |
| 2000 | 1.19 Million USD | 99.51% |
| 1999 | 600 Thousand USD | 50.0% |
| 1998 | 400 Thousand USD | -42.86% |
| 1997 | 700 Thousand USD | -84.09% |
| 1996 | 4.4 Million USD | -71.97% |
| 1995 | 15.7 Million USD | 21.71% |
| 1994 | 12.9 Million USD | -11.64% |
| 1993 | 14.6 Million USD | 342.42% |
| 1992 | 3.3 Million USD | 0.0% |
| 1991 | 3.3 Million USD | -2.94% |
| 1990 | 3.4 Million USD | 21.43% |
| 1989 | 2.8 Million USD | 12.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 878.66 Million USD | 2.98% |
| 2024 Q2 | 875.56 Million USD | -0.35% |
| 2023 Q3 | 525.57 Million USD | -9.08% |
| 2023 Q1 | 597.74 Million USD | -2.64% |
| 2023 Q2 | 578.07 Million USD | -3.29% |
| 2023 FY | 853.2 Million USD | 38.97% |
| 2023 Q4 | 853.2 Million USD | 62.34% |
| 2022 Q4 | 613.95 Million USD | -2.15% |
| 2022 Q3 | 627.42 Million USD | -1.9% |
| 2022 Q1 | 617.42 Million USD | 1.5% |
| 2022 FY | 613.95 Million USD | 0.93% |
| 2022 Q2 | 639.55 Million USD | 3.58% |
| 2021 FY | 608.28 Million USD | 62.76% |
| 2021 Q1 | 371.11 Million USD | -0.7% |
| 2021 Q2 | 412.89 Million USD | 11.26% |
| 2021 Q3 | 526.13 Million USD | 27.42% |
| 2021 Q4 | 608.28 Million USD | 15.61% |
| 2020 Q3 | 351.44 Million USD | 2.76% |
| 2020 Q2 | 342.01 Million USD | 1.57% |
| 2020 Q1 | 336.72 Million USD | -1.06% |
| 2020 FY | 373.73 Million USD | 9.81% |
| 2020 Q4 | 373.73 Million USD | 6.34% |
| 2019 FY | 340.34 Million USD | 119.55% |
| 2019 Q4 | 340.34 Million USD | 2.02% |
| 2019 Q2 | 189.29 Million USD | 9.49% |
| 2019 Q1 | 172.89 Million USD | 11.53% |
| 2019 Q3 | 333.59 Million USD | 76.22% |
| 2018 Q3 | 155.63 Million USD | 6.29% |
| 2018 Q1 | 146.06 Million USD | -3.85% |
| 2018 FY | 155.01 Million USD | 2.04% |
| 2018 Q4 | 155.01 Million USD | -0.4% |
| 2018 Q2 | 146.42 Million USD | 0.24% |
| 2017 Q2 | 117.82 Million USD | 3.5% |
| 2017 Q1 | 113.83 Million USD | -5.25% |
| 2017 Q4 | 151.91 Million USD | -3.46% |
| 2017 FY | 151.91 Million USD | 26.44% |
| 2017 Q3 | 157.36 Million USD | 33.57% |
| 2016 Q3 | 118.52 Million USD | -0.05% |
| 2016 FY | 120.14 Million USD | 411.51% |
| 2016 Q4 | 120.14 Million USD | 1.37% |
| 2016 Q2 | 118.58 Million USD | 543.16% |
| 2016 Q1 | 18.43 Million USD | -21.5% |
| 2015 Q4 | 23.48 Million USD | 27.64% |
| 2015 Q1 | 16.65 Million USD | 7.7% |
| 2015 Q3 | 18.4 Million USD | -3.77% |
| 2015 Q2 | 19.12 Million USD | 14.83% |
| 2015 FY | 23.48 Million USD | 51.92% |
| 2014 Q4 | 15.46 Million USD | 8.52% |
| 2014 Q3 | 14.24 Million USD | 5.64% |
| 2014 FY | 15.46 Million USD | 4.76% |
| 2014 Q1 | 10.48 Million USD | -28.97% |
| 2014 Q2 | 13.48 Million USD | 28.66% |
| 2013 Q1 | 9.9 Million USD | -23.14% |
| 2013 FY | 14.75 Million USD | 14.54% |
| 2013 Q2 | 12.2 Million USD | 23.21% |
| 2013 Q3 | 11.47 Million USD | -5.92% |
| 2013 Q4 | 14.75 Million USD | 28.56% |
| 2012 Q1 | 11.72 Million USD | 0.0% |
| 2012 Q2 | 12.71 Million USD | 8.49% |
| 2012 Q3 | 11.19 Million USD | -12.0% |
| 2012 Q4 | 12.88 Million USD | 15.13% |
| 2012 FY | 12.88 Million USD | 147.45% |
| 2011 Q1 | 5.2 Million USD | 23.48% |
| 2011 Q2 | 4.29 Million USD | -17.57% |
| 2011 Q3 | 4.73 Million USD | 10.27% |
| 2011 FY | 5.2 Million USD | -1.74% |
| 2010 Q1 | 5.29 Million USD | 32.74% |
| 2010 FY | 5.29 Million USD | 14.43% |
| 2010 Q4 | 4.21 Million USD | -3.4% |
| 2010 Q3 | 4.36 Million USD | 4.62% |
| 2010 Q2 | 4.17 Million USD | -21.27% |
| 2009 Q4 | 3.99 Million USD | -2.26% |
| 2009 FY | 4.63 Million USD | -2.15% |
| 2009 Q1 | 4.63 Million USD | 20.54% |
| 2009 Q2 | 3.19 Million USD | -30.96% |
| 2009 Q3 | 4.08 Million USD | 27.74% |
| 2008 Q2 | 2.82 Million USD | -40.23% |
| 2008 FY | 4.73 Million USD | 33.79% |
| 2008 Q1 | 4.73 Million USD | 41.87% |
| 2008 Q3 | 3.23 Million USD | 14.42% |
| 2008 Q4 | 3.84 Million USD | 18.7% |
| 2007 FY | 3.53 Million USD | 11.73% |
| 2007 Q1 | 3.53 Million USD | -1.24% |
| 2007 Q2 | 3.52 Million USD | -0.35% |
| 2007 Q4 | 3.33 Million USD | -16.2% |
| 2007 Q3 | 3.98 Million USD | 12.94% |
| 2006 Q2 | 2.92 Million USD | -7.61% |
| 2006 Q4 | 3.58 Million USD | 23.54% |
| 2006 Q1 | 3.16 Million USD | -5.96% |
| 2006 FY | 3.16 Million USD | -4.56% |
| 2006 Q3 | 2.89 Million USD | -0.88% |
| 2005 Q2 | 2.48 Million USD | -24.99% |
| 2005 FY | 3.31 Million USD | 35.36% |
| 2005 Q1 | 3.31 Million USD | 21.81% |
| 2005 Q4 | 3.36 Million USD | 10.31% |
| 2005 Q3 | 3.05 Million USD | 22.66% |
| 2004 Q2 | 2.43 Million USD | -0.59% |
| 2004 Q3 | 2.48 Million USD | 2.02% |
| 2004 Q4 | 2.72 Million USD | 9.57% |
| 2004 FY | 2.45 Million USD | 9.25% |
| 2004 Q1 | 2.45 Million USD | -12.7% |
| 2003 Q4 | 2.8 Million USD | 2.59% |
| 2003 Q3 | 2.73 Million USD | 15.28% |
| 2003 FY | 2.24 Million USD | -15.88% |
| 2003 Q1 | 2.24 Million USD | 31.92% |
| 2003 Q2 | 2.37 Million USD | 5.81% |
| 2002 Q4 | 1.7 Million USD | -57.85% |
| 2002 Q3 | 4.03 Million USD | -16.25% |
| 2002 Q2 | 4.81 Million USD | 80.66% |
| 2002 Q1 | 2.66 Million USD | 98.05% |
| 2002 FY | 2.66 Million USD | 112.18% |
| 2001 Q4 | 1.34 Million USD | -9.55% |
| 2001 Q3 | 1.48 Million USD | 32.57% |
| 2001 Q2 | 1.12 Million USD | -10.65% |
| 2001 Q1 | 1.25 Million USD | 9.33% |
| 2001 FY | 1.25 Million USD | 4.99% |
| 2000 Q3 | 968.03 Thousand USD | 23.16% |
| 2000 FY | 1.19 Million USD | 99.51% |
| 2000 Q2 | 785.96 Thousand USD | -34.34% |
| 2000 Q4 | 1.14 Million USD | 18.76% |
| 2000 Q1 | 1.19 Million USD | 139.42% |
| 1999 Q4 | 500 Thousand USD | 0.0% |
| 1999 Q2 | 700 Thousand USD | 16.67% |
| 1999 Q1 | 600 Thousand USD | 50.0% |
| 1999 FY | 600 Thousand USD | 50.0% |
| 1999 Q3 | 500 Thousand USD | -28.57% |
| 1998 FY | 400 Thousand USD | -42.86% |
| 1998 Q1 | 400 Thousand USD | 33.33% |
| 1998 Q2 | 500 Thousand USD | 25.0% |
| 1998 Q3 | 500 Thousand USD | 0.0% |
| 1998 Q4 | 400 Thousand USD | -20.0% |
| 1997 Q1 | 700 Thousand USD | -12.5% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 300 Thousand USD | -40.0% |
| 1997 Q2 | 500 Thousand USD | -28.57% |
| 1997 FY | 700 Thousand USD | -84.09% |
| 1996 FY | 4.4 Million USD | -71.97% |
| 1996 Q2 | 900 Thousand USD | -79.55% |
| 1996 Q3 | 600 Thousand USD | -33.33% |
| 1996 Q4 | 800 Thousand USD | 33.33% |
| 1996 Q1 | 4.4 Million USD | -45.0% |
| 1995 Q1 | 15.7 Million USD | 23.62% |
| 1995 Q2 | 8.9 Million USD | -43.31% |
| 1995 Q4 | 8 Million USD | -16.67% |
| 1995 Q3 | 9.6 Million USD | 7.87% |
| 1995 FY | 15.7 Million USD | 21.71% |
| 1994 FY | 12.9 Million USD | -11.64% |
| 1994 Q3 | 11.2 Million USD | -5.88% |
| 1994 Q4 | 12.7 Million USD | 13.39% |
| 1994 Q1 | 12.9 Million USD | 5.74% |
| 1994 Q2 | 11.9 Million USD | -7.75% |
| 1993 Q1 | 14.6 Million USD | 97.3% |
| 1993 Q2 | 11.5 Million USD | -21.23% |
| 1993 Q3 | 11.1 Million USD | -3.48% |
| 1993 FY | 14.6 Million USD | 342.42% |
| 1993 Q4 | 12.2 Million USD | 9.91% |
| 1992 Q3 | 6.8 Million USD | 65.85% |
| 1992 FY | 3.3 Million USD | 0.0% |
| 1992 Q4 | 7.4 Million USD | 8.82% |
| 1992 Q1 | 3.3 Million USD | 17.86% |
| 1992 Q2 | 4.1 Million USD | 24.24% |
| 1991 Q1 | 3.3 Million USD | 26.92% |
| 1991 FY | 3.3 Million USD | -2.94% |
| 1991 Q2 | 2.8 Million USD | -15.15% |
| 1991 Q3 | 2.5 Million USD | -10.71% |
| 1991 Q4 | 2.8 Million USD | 12.0% |
| 1990 FY | 3.4 Million USD | 21.43% |
| 1990 Q1 | 3.4 Million USD | 0.0% |
| 1990 Q2 | 2.8 Million USD | -17.65% |
| 1990 Q4 | 2.6 Million USD | 4.0% |
| 1990 Q3 | 2.5 Million USD | -10.71% |
| 1989 Q1 | 2.8 Million USD | 0.0% |
| 1989 FY | 2.8 Million USD | 12.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -573.945% |
| AngioDynamics, Inc. | 112.08 Million USD | -661.215% |
| AtriCure, Inc. | 147.76 Million USD | -477.413% |
| Avinger, Inc. | 19.97 Million USD | -4172.021% |
| Azenta, Inc. | 351.22 Million USD | -142.927% |
| BioLife Solutions, Inc. | 75.05 Million USD | -1036.838% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 79.23% |
| Daxor Corporation | 858.75 Thousand USD | -99253.718% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -5130.554% |
| Femasys Inc. | 9.4 Million USD | -8973.557% |
| GlucoTrack, Inc. | 1.7 Million USD | -49853.63% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -1227.083% |
| Hologic, Inc. | 4.02 Billion USD | 78.808% |
| ICU Medical, Inc. | 2.25 Billion USD | 62.164% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 58.262% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -10424.076% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -1645.587% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -129186.476% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -129186.476% |
| Masimo Corporation | 1.67 Billion USD | 49.114% |
| Microbot Medical Inc. | 3.82 Million USD | -22200.261% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -3302.292% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 24.041% |
| Nephros, Inc. | 3.5 Million USD | -24256.494% |
| NovoCure Limited | 783.63 Million USD | -8.879% |
| NEXGEL, Inc. | 4.78 Million USD | -17715.995% |
| NEXGEL, Inc. | 4.78 Million USD | -17715.995% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -886.813% |
| OraSure Technologies, Inc. | 52.17 Million USD | -1535.313% |
| Pro-Dex, Inc. | 23.34 Million USD | -3555.091% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -5088.568% |
| Predictive Oncology Inc. | 6.14 Million USD | -13783.529% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -12365.079% |
| QuidelOrtho Corporation | 3.55 Billion USD | 76.015% |
| Sanara MedTech Inc. | 29.28 Million USD | -2813.65% |
| STAAR Surgical Company | 102.73 Million USD | -730.47% |
| Sharps Technology, Inc. | 3.85 Million USD | -22032.607% |
| Utah Medical Products, Inc. | 7.14 Million USD | -11841.33% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 79.068% |
| Jin Medical International Ltd. | 8.92 Million USD | -9460.455% |